Lawas, Baby Boy M.

HRN: 21-47-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2024
CEFUROXIME 750MG (VIAL)
03/23/2024
03/29/2024
IV
350
Q8
AGE
Waiting Final Action 
03/23/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/23/2024
03/29/2024
ORAL
6ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: